Rofecoxib, selective COX-2 inhibitors and cardiovascular risk

被引：0
作者：
Dhaun, N. [1 ]
Maxwell, S. R. J. [1 ]
Webb, D. J. [2 ]
机构：
[1] Univ Edinburgh, Therapeut & Pharmacol, Edinburgh, Midlothian, Scotland
[2] Univ Edinburgh, Clin Pharmacol Unit, Edinburgh, Midlothian, Scotland
来源：
JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH | 2005年 / 35卷 / 02期
关键词：
Cardiovascular risk; Rofecoxib; selective COX-2 inhibitors;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：101 / 103
页数：3
相关论文
共 7 条
[1]   Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. [J].
Bombardier, C ;
Laine, L ;
Reicin, A ;
Shapiro, D ;
Burgos-Vargas, R ;
Davis, B ;
Day, R ;
Ferraz, MB ;
Hawkey, CJ ;
Hochberg, MC ;
Kvien, TK ;
Schnitzer, TJ ;
Weaver, A .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (21) :1520-1528
[2]   Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial [J].
Bresalier, RS ;
Sandler, RS ;
Quan, H ;
Bolognese, JA ;
Oxenius, B ;
Horgan, K ;
Lines, C ;
Riddell, R ;
Morton, D ;
Lanas, A ;
Konstam, MA ;
Baron, JA .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (11) :1092-1102
[3]   Parecoxib, valdecoxib, and cardiovascular risk [J].
Furberg, CD ;
Psaty, BM ;
FitzGerald, GA .
CIRCULATION, 2005, 111 (03) :249-249
[4]   Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis - The CLASS study: A randomized controlled trial [J].
Silverstein, FE ;
Faich, G ;
Goldstein, JL ;
Simon, LS ;
Pincus, T ;
Whelton, A ;
Makuch, R ;
Eisen, G ;
Agarwal, NM ;
Stenson, WF ;
Burr, AM ;
Zhao, WW ;
Kent, JD ;
Lefkowith, JB ;
Verburg, KM ;
Geis, GS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (10) :1247-1255
[5]   Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention [J].
Solomon, SD ;
McMurray, JJV ;
Pfeffer, MA ;
Wittes, J ;
Fowler, R ;
Finn, P ;
Anderson, WF ;
Zauber, A ;
Hawk, E ;
Bertagnolli, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (11) :1071-1080
[6]   Arthritis medicines and cardiovascular events - "House of coxibs" [J].
Topol, EJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (03) :366-368
[7]  
2005, FDA FACT SHEET FDA I
1